Physician profile
Cindy Wei Tung
NPI 1932152261
$441.43
in general payments reported to CMS, 2019-2025
12 companies · $87.99 in 2025
The $87.99 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
See the full distribution for Adolescent Medicine (Pediatrics)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $83.79 · 2021: $59.35 · 2022: $84.24 · 2023: $30.41 · 2024: $95.65 · 2025: $87.99.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $214.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $91.94 | 2021-2025 | Vaxelis, Gardasil 9, M-M-R II |
| Pfizer INC. | $76.02 | 2019-2025 | |
| Cranial Technologies, INC | $69.41 | 2019-2024 | Doc Band |
| Sanofi Pasteur INC. | $49.40 | 2019-2024 | |
| Glaxosmithkline, LLC. | $29.98 | 2022 | |
| Genentech USA, INC. | $27.33 | 2019-2021 | |
| Qiagen, LLC | $17.87 | 2021 | |
| Viiv Healthcare Company | $17.44 | 2025 | Apretude |
| Optinose US, INC. | $17.14 | 2025 | |
| Alk-Abello, INC | $16.60 | 2025 | Neffy |
| Hikma Pharmaceuticals USA | $16.17 | 2023 | Kloxxado, Mitigare, Ryaltris |
| Kaleo, INC. | $12.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cindy Tung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.